Dr. Alan Joel Ruby , MD
Ophthalmology โข Royal Oak, MI
3555 W 13 Mile Rd, Ll-20
Royal Oak, MI 480736710
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 7, 2006; this date does not establish years in practice.
-
Published CMS data list 25,402 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J2777 โ Injection, faricimab-svoa, 0.1 mg: 15,060 service units.
- 92134 โ Imaging of retina: 2,149 service units.
- J2778 โ Injection, ranibizumab, 0.1 mg: 1,950 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 17 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 299 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Prednisolone Acetate โ 87 prescription fills, including refills.
- Difluprednate โ 62 prescription fills, including refills.
- Ketorolac Tromethamine โ 42 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Royal Oak, MI (2024, 15 clinicians with data). Median for this group: 971. Middle half: 607 to 4,308.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Michigan (2024, 512 clinicians with data). Median for this group: 1,346. Middle half: 560 to 2,503.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 12,756 in 2020 to 25,402 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
3555 W 13 Mile Rd
Ll-20
Royal Oak, MI 480736710
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Associated Retinal Consultants Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Michigan Medical School
1987
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
894 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $2,910,172 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $2,292,655 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
503 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$13,190 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,401.89 across 21 records.
By nature of payment
- Consulting Fee: $724.00 across 1 record.
- Food and Beverage: $677.89 across 20 records.
Reporting-company totals (3 largest of 6)
- Regeneron Pharmaceuticals, Inc.: $875.86 across 7 records.
- ABBVIE INC.: $167.69 across 3 records.
- Astellas Pharma US Inc: $164.14 across 8 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
39 years (graduated 1987)
CMS Doctors and Clinicians data list 1987 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Ruby has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ruby as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Royal Oak and Michigan
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Ophthalmology in Royal Oak, MI (2024, 15 clinicians with data). Median for this group: 971. Middle half: 607 to 4,308.
More Medicare Part B services than 95% of clinicians listed under Ophthalmology in Michigan (2024, 512 clinicians with data). Median for this group: 1,346. Middle half: 560 to 2,503.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Ophthalmology in Royal Oak, MI (2024, 15 clinicians with data). Median for this group: $119,675. Middle half: $57,407 to $216,054.
A higher Medicare-allowed amount than 95% of clinicians listed under Ophthalmology in Michigan (2024, 512 clinicians with data). Median for this group: $137,699. Middle half: $49,630 to $280,968.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Royal Oak, MI (2024, 15 clinicians with data). Median for this group: $82,492. Middle half: $41,177 to $161,112.
A higher Medicare payment amount than 95% of clinicians listed under Ophthalmology in Michigan (2024, 512 clinicians with data). Median for this group: $97,396. Middle half: $34,458 to $203,115.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Ophthalmology in Royal Oak, MI (2024, 20 clinicians with data). Median for this group: 389. Middle half: 54 to 766.
Fewer Part D prescriptions than 75% of clinicians listed under Ophthalmology in Michigan (2024, 554 clinicians with data). Median for this group: 1,008. Middle half: 346 to 1,869.
Part D drug cost
Close to the middle for clinicians listed under Ophthalmology in Royal Oak, MI (2024, 20 clinicians with data). Median for this group: $12,266. Middle half: $1,126 to $55,917.
A lower Part D drug cost than 75% of clinicians listed under Ophthalmology in Michigan (2024, 554 clinicians with data). Median for this group: $69,975. Middle half: $14,648 to $171,442.
35 active clinicians are listed under Ophthalmology with a practice address in Royal Oak, MI (791 in Michigan).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Royal Oak
0% of these 35 clinicians have the CMS telehealth indicator.
51.4% of these 35 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 99% from 12,756 in 2020 to 25,402 in 2024.
- 2020: 12,756
- 2021: 13,137
- 2022: 13,458
- 2023: 21,309
- 2024: 25,402
-
Medicare-allowed amount
Medicare-allowed amount decreased 12% from $3,312,538 in 2020 to $2,910,172 in 2024.
- 2020: $3,312,538
- 2021: $3,526,800
- 2022: $3,236,192
- 2023: $3,044,089
- 2024: $2,910,172
-
Paid by Medicare
Paid by Medicare decreased 12% from $2,607,141 in 2020 to $2,292,655 in 2024.
- 2020: $2,607,141
- 2021: $2,810,978
- 2022: $2,547,761
- 2023: $2,394,839
- 2024: $2,292,655
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 33% from 443 in 2020 to 299 in 2024.
- 2020: 443
- 2021: 407
- 2022: 324
- 2023: 193
- 2024: 299
-
30-day fills
30-day fills decreased 16% from 599 in 2020 to 503 in 2024.
- 2020: 599
- 2021: 533
- 2022: 502
- 2023: 303
- 2024: 503
-
Part D drug cost
Part D drug cost decreased 63% from $35,469 in 2020 to $13,190 in 2024.
- 2020: $35,469
- 2021: $34,007
- 2022: $17,239
- 2023: $11,317
- 2024: $13,190
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 91% from $16,368.86 in 2021 to $1,401.89 in 2025.
- 2021: $16,368.86
- 2022: $1,892.57
- 2023: $1,290.05
- 2024: $2,349.37
- 2025: $1,401.89
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 21 records totaling $1,401.89.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. |
Consulting Fee
Cash or cash equivalent
|
EYLEA HD | General | $724.00 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $161.70 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $122.55 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $35.64 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $34.08 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $25.75 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $25.26 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $24.87 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $23.17 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $21.97 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $21.26 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $20.87 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $20.74 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $20.45 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $20.32 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $19.82 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $18.95 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $16.26 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $15.34 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Izervay | General | $15.34 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
ILUVIEN | General | $13.55 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J2777
Injection, faricimab-svoa, 0.1 mg
|
15,060 | 50 | $44.82 | $34.34 |
|
92134
Imaging of retina
|
2,149 | 758 | $99.88 | $41.72 |
|
J2778
Injection, ranibizumab, 0.1 mg
|
1,950 | 77 | $468.00 | $157.24 |
|
J0178
Injection, aflibercept, 1 mg
|
1,640 | 168 | $1086.80 | $816.32 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,497 | 466 | $219.79 | $134.89 |
|
67028
Injection of drug into eye
|
1,444 | 318 | $308.14 | $132.06 |
|
92014
Established patient complete exam of visual system
|
439 | 357 | $195.00 | $129.65 |
|
J0177
Injection, aflibercept hd, 1 mg
|
288 | 11 | $375.00 | $331.66 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
229 | 160 | $155.00 | $96.18 |
|
J3590
Unclassified biologics
|
223 | 63 | $373.32 | $211.07 |
|
92250
Photography of the retina
|
126 | 111 | $125.00 | $36.73 |
|
92201
Extended exam of the back part of the eye with retinal drawing
|
108 | 95 | $60.00 | $26.07 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
100 | 100 | $280.00 | $176.41 |
|
92235
Exam of retinal blood vessels using a special camera after injection of a dye
|
72 | 70 | $280.00 | $161.39 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
52 | 52 | $190.00 | $117.97 |
|
76512
2d ultrasound scan of eye tissue and structures
|
14 | 12 | $148.57 | $57.35 |
|
92202
Extended exam of the back part of the eye with optic nerve drawing
|
11 | 11 | $45.00 | $16.10 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Prednisolone Acetate | Prednisolone Acetate | 87 | 4,561 | $4,394.35 | 55 |
| Difluprednate | Difluprednate | 62 | 1,951 | $6,093.00 | 28 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 42 | 2,319 | $1,061.39 | 25 |
| Brimonidine Tartrate | Brimonidine Tartrate | 41 | 2,731 | $799.79 | 21 |
| Erythromycin | Erythromycin Base | 22 | 182 | $346.42 | 11 |
| Timolol Maleate | Timolol Maleate | 21 | 902 | $274.93 | โ |
| Latanoprost | Latanoprost | 13 | 629 | $96.06 | โ |
| Dorzolamide Hcl | Dorzolamide Hcl | 11 | 764 | $123.86 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-01-04NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20060921000554
MI
1355253857
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Associated Retinal Consultants Pc
860 E Front St, Traverse City, MI 496862704
Phone: 2319380710
Associated Retinal Consultants Pc
36650 Five Mile Rd, Livonia, MI 481541956
Phone: 7344642300
Associated Retinal Consultants Pc
3555 W 13 Mile Rd, Royal Oak, MI 480736710
Phone: 2482882280
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Ophthalmology - Retina Specialist
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Ophthalmology - Retina Specialist
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 2000 N HURON RIVER DR STE 100200, YPSILANTI, MI 481971699 (Tel: 7345721200)
NPI status registered as active in NPPES database
Registered at 3555 W 13 MILE RD, LL-20, ROYAL OAK, MI 480736710 (Tel: 2482882280)
Registered at 39650 ORCHARD HILL PL, 200, NOVI, MI 483755391 (Tel: 2483190161)
Recorded as ALAN RUBY, MD
Ophthalmology (license number reported to NPPES: MI 4301051388)
Ophthalmology (license number reported to NPPES: MI 43010511388)
NPI status registered as active in NPPES database
Registered at 3555 W 13 MILE RD, LL-20, ROYAL OAK, MI 480736710 (Tel: 2482882280)
Registered at 39650 ORCHARD HILL PL, 200, NOVI, MI 483755391 (Tel: 2483190161)
Recorded as ALAN RUBY, MD
Ophthalmology (license number reported to NPPES: MI 4301051388)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Royal Oak
- Viren Govindaraju
- Dr. Jeffrey Kalt, MD
- Dr. Asad Loya, MD
- Dr. Chirag Gupta, MD
- Dr. Ryan Frisbie, MD, MPH
- Lori Stec
Mailing Address
2000 N Huron River Dr Ste 100200
Ypsilanti, MI 481971699
Phone: 7345721200